Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
ALS is a disorder that weakens motor strength and lung function. Rapid loss of motor neurons
in the brain and spinal cord of ALS patients causes the symptoms of increasing weakness and
loss of muscle function. While there are drugs to help relieve symptoms of ALS, there is no
cure for ALS.
Rasagiline is a drug with possible neuroprotective characteristics. Neuroprotective means
that the nervous system may be protected against weakening. It is known that rasagiline has
possible neuroprotective characteristics and it is approved for use for patients with another
disorder, the effectiveness of rasagiline for patients with ALS has not been tested.